Report Categories
View AllRecent Articles
View All
ATHA AthenePrefA reports steady quarterly dividend on 635 preference shares performance aligns with yield investor expectations
BYRN Byrna posts 697 percent Q1 2026 EPS miss shares dip 171 percent on soft investor sentiment
EWCZ European reports 63 percent EPS surprise for Q4 2025 shares stay flat on no disclosed revenue figures
How Saratoga SAZ is solving the problems its peers cannot 027 20260508
Citi Initiates Coverage on NextDecade NEXT with Buy Rating 11 Price Target
Spotify Shares Surge 13 on AI Deal with Universal Music and LongTerm Revenue Guidance
Nvidia Shares Slip Despite 85 Revenue Surge as AI Boom Continues to Fuel Growth
Portfolio Manager Trims Position After Parabolic Surge of 80 Since April
Federal Realty Investment Trust Outpaces SP 500 in 2026 Amid Steady REIT Performance
Robert Kiyosaki Predicts Potential Surge in Gold and Silver Prices Amid Stock Market Crash Warnings
Traeger Inc COOK Q1 2026 Earnings Surprise Profitability Defies Expectations
Agilysys Q1 2026 Earnings EPS Surpasses Expectations by 244 Amid Concerns Over Revenue Disclosure
Fortive Q1 2026 Earnings Strong EPS Beat Bolsters Investor Confidence
CRVL Q1 2026 Earnings CorVel Posts 061 EPS as Stock Gains 195
Kimball Electronics Q1 2026 Earnings EPS Miss Drags Shares Lower
ADAMZ Q1 2026 Earnings Preferred Stock Delivers Strong EPS Beat Despite Modest Share Decline
Oxford Lane Capital 2029 Preferred Shares OXLCO Hold Steady as FixedIncome Market Finds Footing
Borealis Foods Warrants BRLSW Plunge Extends Support at 005 in Focus
Pacific Biosciences PACB Edges Higher But Key Resistance Remains a Hurdle
IHS Holding IHS Gains 096 as Stock Approaches Key Technical Resistance
Nektar Therapeutics NKTR Navigates a 287 Decline as Key Support Levels Come Into Focus
ProFrac Holding Corp ACDC Edges Lower Amid Consolidation Pressures
Biogen BIIB Gains 130 as Sector Support Holds Key Resistance in Focus
Shinhan Financial Group SHG Edges Higher as Support Levels Hold Steady
SAGTEC GLOBAL LIMITED SAGT Suffers 38 Decline Approaches Critical Support at 096
UroGen Pharma URGN Advances 197 Approaching Key Resistance at 3093
External Links
Jim Cramer Highlights Two Stocks Points to Potential Upside in One
Baidu Q1 2026 Earnings EPS Beats Estimates but Stock Slides Amid Revenue Uncertainty
Rising Dragon Acquisition Corp RDAC Holds Steady Near 930 Amid SPAC Uncertainty
First United Corporation FUNC Gains 155 as Stock Approaches Key Resistance Level
Varonis Systems VRNS Holds Steady Amid Minor Dip Key Levels in Focus
Kymera Therapeutics KYMR Retreats 148 as Stock Tests Key Support Level
Seadrill SDRL Slips 13 as Offshore Drilling Stock Tests Key Support Levels
Altisource Portfolio Solutions ASPS Edges Lower as Stock Tests Key Support Zone
Halozyme Therapeutics HALO Rises Modestly Support and Resistance Levels in Focus
BitVentures Limited BVC Holds Steady at 1067 as Consolidation Pattern Emerges